Belite Bio, Inc (BLTE)
$154.49+1.29%Close
SELLBEAR · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6.2B
- Beta
- -1.23
- P/E (TTM)
- -56.38
- Short % float
- 5.73%
- Days to cover
- 7.3
- SI change
- +0.7%
- 1W
- -3.18%
- 1M
- -11.76%
- vs SPY 1W
- -4.34%
- vs SPY 1M
- -14.75%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on BLTE?
- LOPJLB’s latest quantitative signal on Belite Bio, Inc (BLTE) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is BLTE in?
- Belite Bio, Inc (BLTE) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Belite Bio, Inc (BLTE) do?
- Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical tria…